Eco R1 Capital, LLC T Scan Therapeutics, Inc. Transaction History
Eco R1 Capital, LLC
- $3.51 Billion
- Q1 2024
A detailed history of Eco R1 Capital, LLC transactions in T Scan Therapeutics, Inc. stock. As of the latest transaction made, Eco R1 Capital, LLC holds 5,000,000 shares of TCRX stock, worth $42.8 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
5,000,000
Previous 5,000,000
-0.0%
Holding current value
$42.8 Million
Previous $29.2 Million
36.19%
% of portfolio
1.13%
Previous 0.84%
Shares
1 transactions
Others Institutions Holding TCRX
# of Institutions
67Shares Held
29.3MCall Options Held
0Put Options Held
0-
Adage Capital Partners Gp, L.L.C. Boston, MA3.9MShares$33.3 Million0.06% of portfolio
-
Bvf Inc San Francisco, CA2.99MShares$25.6 Million0.71% of portfolio
-
Baker Bros. Advisors LP New York, NY2.78MShares$23.8 Million0.28% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA2.09MShares$17.8 Million9.65% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$15.5 Million0.0% of portfolio
About TScan Therapeutics, Inc.
- Ticker TCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,929,800
- Market Cap $162M
- Description
- TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...